The influenza virus haemagglutinin (HA) glycoprotein is being
studied both as a prototype membrane surface molecule and as a
functional component of a viral envelope. X-ray crystallographic
studies of the HA from the human, 1968 Hong Kong virus strain
produced atomic models from which chemically detailed conclusions
about virus functions can be deduced. The detail of these models
also permits the design of biochemical, recombinant DNA, and cell
biological experiments on the mechanisms of the viral activities.
A long-term goal is to develop strategies to intervene in the
viral processes to prevent infection.
How the virus binds to cells is being studied by X-ray structural
analysis of complexes between the HA and synthetic receptor
analogs and with complexes between sialocides and affinity
mutants of the HA. The structure of the HA from an animal
influenza virus Duck/Ukraine/63 the progenitor of the 1968 human
Hong Kong strain will be determined. The energetics of the
receptor binding interactions are being measured in parallel with
X-ray experiments by NMR. Recombinant DNA methods are being used
to create site-directed mutations in the interacting residues and
to provide quantities of novel molecular species for NMR and X-
ray studies.
The mechanism of membrane-fusion by which many enveloped animal
virus enter cells is being studied by structural analysis of a
fusion active and precursor, inactive form of the HA. The
structure of membrane fusion mutants and a second fusion active
glycoprotein from Influenza C virus are also being studied.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
X ray crystallographyantibody inhibitorantibody receptorantigen receptorsargininecarbopolycyclic compoundcardiac glycosideschemical bindingdisease /disorder modelgenetic strainglycoproteinshemagglutininhigh performance liquid chromatographyligandsmembrane fusionmembrane modelmembrane proteinsmembrane structuremutantnuclear magnetic resonance spectroscopynucleic acid sequenceparainfluenza virus type 1protein structurereceptor bindingrecombinant DNAsialatesite directed mutagenesissurface antigensthermolysinvirus antigenvirus envelopevirus infection mechanismvirus proteinvirus replication
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
082359691
UEI
LN53LCFJFL45
Project Start Date
01-January-1977
Project End Date
31-May-1995
Budget Start Date
01-January-1994
Budget End Date
31-May-1995
Project Funding Information for 1994
Total Funding
$179,812
Direct Costs
$106,084
Indirect Costs
$73,728
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Allergy and Infectious Diseases
$179,812
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI013654-18
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI013654-18
Patents
No Patents information available for 5R01AI013654-18
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI013654-18
Clinical Studies
No Clinical Studies information available for 5R01AI013654-18
News and More
Related News Releases
No news release information available for 5R01AI013654-18
History
No Historical information available for 5R01AI013654-18
Similar Projects
No Similar Projects information available for 5R01AI013654-18